$YYAI
Connexa Sports Technologies Inc.

2023 Q4 Form 10-Q Financial Statement

#000149315223042728 Filed on November 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q4
Revenue $2.296M
YoY Change -41.94%
Cost Of Revenue $1.649M
YoY Change -47.7%
Gross Profit $647.0K
YoY Change -19.27%
Gross Profit Margin 28.18%
Selling, General & Admin $1.921M
YoY Change -68.84%
% of Gross Profit 296.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.921M
YoY Change -73.41%
Operating Profit -$1.274M
YoY Change -80.16%
Interest Expense $3.050M
YoY Change -402.1%
% of Operating Profit
Other Income/Expense, Net $3.037M
YoY Change -166.01%
Pretax Income $1.762M
YoY Change -115.99%
Income Tax
% Of Pretax Income
Net Earnings $1.762M
YoY Change -115.99%
Net Earnings / Revenue 76.75%
Basic Earnings Per Share -$14.29
Diluted Earnings Per Share -$14.29
COMMON SHARES
Basic Shares Outstanding 774.0K shares
Diluted Shares Outstanding 912.1K shares

Balance Sheet

Concept 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $285.9K
YoY Change -38.53%
Cash & Equivalents $285.9K
Short-Term Investments
Other Short-Term Assets $980.6K
YoY Change -50.25%
Inventory $1.668M
Prepaid Expenses
Receivables $528.0K
Other Receivables $0.00
Total Short-Term Assets $3.463M
YoY Change -56.98%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.001M
YoY Change -96.72%
TOTAL ASSETS
Total Short-Term Assets $3.463M
Total Long-Term Assets $2.001M
Total Assets $5.464M
YoY Change -92.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.113M
YoY Change -10.48%
Accrued Expenses $5.047M
YoY Change -33.16%
Deferred Revenue
YoY Change
Short-Term Debt $3.195M
YoY Change 297.51%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.46M
YoY Change -35.65%
LONG-TERM LIABILITIES
Long-Term Debt $1.399M
YoY Change -30.06%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.399M
YoY Change -56.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.46M
Total Long-Term Liabilities $1.399M
Total Liabilities $19.86M
YoY Change -37.73%
SHAREHOLDERS EQUITY
Retained Earnings -$150.8M
YoY Change 57.31%
Common Stock $136.2M
YoY Change 2.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.40M
YoY Change
Total Liabilities & Shareholders Equity $5.464M
YoY Change -92.09%

Cashflow Statement

Concept 2023 Q4
OPERATING ACTIVITIES
Net Income $1.762M
YoY Change -115.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$918.1K
YoY Change -71.23%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.254M
YoY Change -35.3%
NET CHANGE
Cash From Operating Activities -918.1K
Cash From Investing Activities
Cash From Financing Activities 1.254M
Net Change In Cash 336.4K
YoY Change -126.86%
FREE CASH FLOW
Cash From Operating Activities -$918.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001674440
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2022Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
usd
CY2023Q4 CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
usd
CY2022Q4 CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
usd
CY2023Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
usd
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
CY2022Q4 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
usd
CY2023Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022Q4 CNXA Stock Issued During Period Cashless Exercise Of Warrants Value
StockIssuedDuringPeriodCashlessExerciseOfWarrantsValue
usd
CY2022Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2023Q3 CNXA Stock Issued During Period Cashless Exercise Of Warrants Value
StockIssuedDuringPeriodCashlessExerciseOfWarrantsValue
usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2023Q4 CNXA Stock Issued During Period Value Fractional Adjustment In Reverse Split
StockIssuedDuringPeriodValueFractionalAdjustmentInReverseSplit
usd
CY2023Q4 CNXA Stock Issued During Period Cashless Exercise Of Warrants Value
StockIssuedDuringPeriodCashlessExerciseOfWarrantsValue
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
CNXA Settlement Expense
SettlementExpense
usd
CNXA Loss On Settlement Of Accounts Payable
LossOnSettlementOfAccountsPayable
usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CNXA Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
usd
CNXA Derivative Liability Recorded For Shares And Warrants Issued In Private Placement
DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
01-41423
dei Entity Registrant Name
EntityRegistrantName
CONNEXA SPORTS TECHNOLOGIES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1789640
dei Entity Address Address Line1
EntityAddressAddressLine1
2709 NORTH ROLLING ROAD
dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 138
dei Entity Address City Or Town
EntityAddressCityOrTown
WINDSOR MILL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21244
dei City Area Code
CityAreaCode
(443)
dei Local Phone Number
LocalPhoneNumber
407-7564
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
CNXA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3436174 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
285861 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202095 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
527998 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
399680 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1668189 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
3189766 usd
CY2023Q4 CNXA Prepaid Inventory Current
PrepaidInventoryCurrent
707612 usd
CY2023Q2 CNXA Prepaid Inventory Current
PrepaidInventoryCurrent
936939 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
272949 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263020 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3462609 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
4991500 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
2000000 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
2000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14791 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
101281 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2001000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2116072 usd
CY2023Q4 us-gaap Assets
Assets
5463609 usd
CY2023Q2 us-gaap Assets
Assets
7107572 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5113362 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5496629 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5047118 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4911839 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3194799 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1484647 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3777148 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10489606 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
418455 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
361804 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22971 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18462477 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23767491 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1398775 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1953842 usd
CY2023Q4 us-gaap Liabilities
Liabilities
19861252 usd
CY2023Q2 us-gaap Liabilities
Liabilities
25721333 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2372803 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2372803 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
338579 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
338579 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2373 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
339 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
136224410 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
132993998 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150835256 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151750610 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
210830 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
142512 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-14397643 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-18613761 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5463609 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7107572 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5416149 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6027157 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2295918 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2443821 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3876437 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4718824 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1648955 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2156780 usd
us-gaap Gross Profit
GrossProfit
1539712 usd
us-gaap Gross Profit
GrossProfit
1308333 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
646963 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
287041 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
547390 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1103952 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
305037 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
347129 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4121385 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7751470 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1616325 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4436860 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34405 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14980 usd
us-gaap Operating Expenses
OperatingExpenses
4668775 usd
us-gaap Operating Expenses
OperatingExpenses
8889827 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
1921362 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
4798969 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3129063 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7581494 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1274399 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4511928 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
790262 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2872222 usd
CY2023Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
13070 usd
CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
289980 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
16944807 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
6787597 usd
CY2023Q4 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
14800253 usd
CY2022Q4 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3100102 usd
CNXA Derivative Expense
DerivativeExpense
11398589 usd
CNXA Derivative Expense
DerivativeExpense
7280405 usd
CY2023Q4 CNXA Derivative Expense
DerivativeExpense
11398589 usd
CY2022Q4 CNXA Derivative Expense
DerivativeExpense
7280405 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4044417 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4045024 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3036518 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4607873 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
915354 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11626518 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1762119 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9119801 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-3663480 usd
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-1903766 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-3663480 usd
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1903766 usd
CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
915354 usd
CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15289998 usd
CY2023Q4 CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1762119 usd
CY2022Q4 CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11023567 usd
us-gaap Net Income Loss
NetIncomeLoss
915354 usd
us-gaap Net Income Loss
NetIncomeLoss
-15289998 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1762119 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-11023567 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
68318 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58139 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
95338 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34630 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
983672 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15231859 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1857457 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11058197 usd
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-23.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-23.13
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2708.25
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2708.25
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-14.29
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-14.29
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3211.20
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-3211.20
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-853.36
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-853.36
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-670.34
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-670.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-23.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-23.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3561.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3561.61
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14.29
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.29
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3881.54
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3881.54
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
693092 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
693092 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4293 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4293 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
912147 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
912147 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2840 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2840 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
32511932 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
14046300 usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
915545 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35250 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4195000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
277625 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
58139 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4266431 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
47773360 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
277625 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
113597 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-11023567 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
37141015 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-18613761 usd
CY2023Q3 CNXA Stock Issued During Period Value Accounts Payable
StockIssuedDuringPeriodValueAccountsPayable
559980 usd
CY2023Q3 CNXA Stock Issued During Period Value Satisfaction Of Profit Guarantee On Note Payable
StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
558294 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27020 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-846765 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-18369272 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-18369272 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
28062 usd
CY2023Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
418455 usd
CY2023Q4 CNXA Stock Issued During Period Value Satisfaction Of Profit Guarantee On Note Payable
StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
210801 usd
CY2023Q4 CNXA Reclassification Of Derivative Liability Upon Amendment Of Agreement
ReclassificationOfDerivativeLiabilityUponAmendmentOfAgreement
1456854 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
95338 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1762119 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-14397643 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-14397643 usd
us-gaap Net Income Loss
NetIncomeLoss
915354 usd
us-gaap Net Income Loss
NetIncomeLoss
-15289998 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
115072 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
71336 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
16944807 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
6787597 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
28062 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
35250 usd
us-gaap Share Based Compensation
ShareBasedCompensation
555250 usd
CNXA Derivative Expense
DerivativeExpense
11398589 usd
CNXA Derivative Expense
DerivativeExpense
7280405 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
790262 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2872222 usd
CNXA Settlement Expense
SettlementExpense
769095 usd
CNXA Loss On Settlement Of Accounts Payable
LossOnSettlementOfAccountsPayable
289980 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-214355 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-396322 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1521577 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3550026 usd
CNXA Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
-229327 usd
CNXA Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
311972 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6573 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
228861 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-648122 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-617142 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
654871 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
10974 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1563410 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
6991994 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-648056 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8298004 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
2298552 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-648056 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5999452 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9194882 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1276000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
556025 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
14133 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
65496 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3835676 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
654479 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5345073 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77343 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
181249 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
83766 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-473130 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
202095 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
665002 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
285861 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
191872 usd
CNXA Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
14046300 usd
CNXA Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
418455 usd
CNXA Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
915545 usd
CNXA Derivative Liability Recorded For Shares And Warrants Issued In Private Placement
DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement
4999882 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2023Q4 CNXA Impact Of Israel And Hamas Conflict Description
ImpactOfIsraelAndHamasConflictDescription
the Central Bank of Israel announced its intent to sell up to $30 billion order to protect the New Israeli Shekel (“NIS”) from collapse, however despite the foregoing announcement the NIS weakened to approximately 3.92 NIS for one US dollar as of the same day. In addition, on October 9, 2023, the Tel Aviv-35 stock index of blue-chip companies dropped by 6.4% whereas the benchmark TA-125 index fell by 6.2%.
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150835256 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_z2hxubgHi6o4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zRrAApvcZeLl">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zl221EorbWof" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_za1Jj6T6MMq7">Financial Statement Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with the current year presentation and had no effect on the Company’s balance sheet, net loss, shareholders’ deficit or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
350000 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
550000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1668189 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
200000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
209690 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
400147 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1509985 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1593591 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1712553 usd
CY2023Q4 CNXA Capitalized Duty And Freight
CapitalizedDutyAndFreight
24451 usd
CY2023Q2 CNXA Capitalized Duty And Freight
CapitalizedDutyAndFreight
517228 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
3189766 usd
CY2023Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zrihGfPXfrva" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zvYPdmg4fHFf">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. See Note 4 for further details on the Company’s concentration of credit risk as well as other risks and uncertainties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
3777148 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
17229161 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1929686 usd
CY2023Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1535186 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
100281 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
14791 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35000 usd
us-gaap Net Income Loss
NetIncomeLoss
915354 usd
CNXA Gain Loss On Change In Fair Value Of Derivatives Liability
GainLossOnChangeInFairValueOfDerivativesLiability
16944807 usd
CNXA Adjusted Net Income Loss
AdjustedNetIncomeLoss
-16029453 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
693092 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-23.13
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1762119 usd
CY2023Q4 CNXA Gain Loss On Change In Fair Value Of Derivatives Liability
GainLossOnChangeInFairValueOfDerivativesLiability
14800253 usd
CY2023Q4 CNXA Adjusted Net Income Loss
AdjustedNetIncomeLoss
-13038134 usd
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
912147 shares
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.29
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2890 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1983178 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1720606 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
490424 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1099254 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1165623 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5047118 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4911839 usd
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2092700 usd
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
109737 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
13200000 shares
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
846301 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
122222 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1501914 usd
CY2021Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1250004 usd
CY2022Q1 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
4000000 usd
CY2023 CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
4000000 usd
CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
4000000 usd
CY2022Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-07-01
CY2022Q3 CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
500000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2372803 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2372803 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
338579 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
338579 shares
CY2023Q3 us-gaap Shares Issued
SharesIssued
189718 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188 usd
CY2023Q3 CNXA Stock Issued During Period Shares Issued Settlement Of Accounts Payable
StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable
67500 shares
CY2023Q3 CNXA Stock Issued During Period Shares Issued Settlement
StockIssuedDuringPeriodSharesIssuedSettlement
1350 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
27000 shares
CY2023Q3 CNXA Stock Issued During Period Shares Issued Profit Guarantee On Note
StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote
93680 shares
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1844506 shares
CY2023Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
13707 shares
CY2023Q4 CNXA Stock Issued During Period Shares Issued For Contingent Consideration
StockIssuedDuringPeriodSharesIssuedForContingentConsideration
1964 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
1708152 shares
CY2023Q4 CNXA Stock Issued During Period Shares Issued Profit Guarantee On Note
StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote
85000 shares
CY2023Q4 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
35683 shares
CY2023Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 40 reverse split
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
151579 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
109737 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
48098 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
675 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
6993 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
150 shares
us-gaap Payments For Rent
PaymentsForRent
4548 usd
us-gaap Payments For Rent
PaymentsForRent
17000 usd
CY2023Q1 CNXA Fair Value Of Common Stock
FairValueOfCommonStock
1334000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
14960 shares
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
418455 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11700000 usd
CY2022Q4 us-gaap Cash
Cash
500000 usd
CY2022Q4 us-gaap Investments
Investments
500000 usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
2873671 usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
6700528 usd
CNXA Disposal Group Including Discontinued Operation Other Income Loss
DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
-163377 usd
CNXA Disposal Group Including Discontinued Operation Net Income Loss
DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss
-3663480 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1510558 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
3422259 usd
CY2023Q4 CNXA Disposal Group Including Discontinued Operation Other Income Loss
DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
-7935 usd
CY2023Q4 CNXA Disposal Group Including Discontinued Operation Net Income Loss
DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss
-1903766 usd

Files In Submission

Name View Source Status
cnxa-20231031_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001493152-23-042728-index-headers.html Edgar Link pending
0001493152-23-042728-index.html Edgar Link pending
0001493152-23-042728.txt Edgar Link pending
0001493152-23-042728-xbrl.zip Edgar Link pending
cnxa-20231031.xsd Edgar Link pending
ex10-4.htm Edgar Link pending
ex10-4_001.jpg Edgar Link pending
ex10-4_002.jpg Edgar Link pending
ex10-4_003.jpg Edgar Link pending
ex10-4_004.jpg Edgar Link pending
ex10-4_005.jpg Edgar Link pending
ex10-4_006.jpg Edgar Link pending
ex10-4_007.jpg Edgar Link pending
ex10-4_008.jpg Edgar Link pending
ex10-4_009.jpg Edgar Link pending
ex10-4_010.jpg Edgar Link pending
ex10-4_013.jpg Edgar Link pending
ex10-4_019.jpg Edgar Link pending
ex10-5.htm Edgar Link pending
ex10-5_001.jpg Edgar Link pending
ex10-5_002.jpg Edgar Link pending
ex10-5_003.jpg Edgar Link pending
ex10-5_004.jpg Edgar Link pending
ex10-5_005.jpg Edgar Link pending
ex10-5_006.jpg Edgar Link pending
ex10-5_007.jpg Edgar Link pending
ex10-5_008.jpg Edgar Link pending
ex10-5_009.jpg Edgar Link pending
ex10-5_010.jpg Edgar Link pending
ex10-5_011.jpg Edgar Link pending
ex10-5_012.jpg Edgar Link pending
cnxa-20231031_pre.xml Edgar Link unprocessable
cnxa-20231031_def.xml Edgar Link unprocessable
ex10-5_020.jpg Edgar Link pending
ex10-5_022.jpg Edgar Link pending
ex10-5_023.jpg Edgar Link pending
ex10-5_024.jpg Edgar Link pending
ex10-6_017.jpg Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cnxa-20231031_cal.xml Edgar Link unprocessable